The global market for cytotoxicity assays is on a rapid growth trajectory, with a Year-on-Year (Y-o-Y) increase of 8.4% in 2022, reaching a value of USD 13,803.92 Million, up from USD 12,732.37 ...

We recently compiled a list of the 10 Best Low Volatility Stocks to Invest in Now. In this article, we are going to take a ...

The global biopharmaceutical market saw a 2% increase in market capitalization in Q3 2024, led by growth from Bristol-Myers ...

This news release of Merck & Co., Inc., Rahway ... industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; ...

We recently made a list of UBS’ Best Stocks In The AI, Growth & Low Rates Era: Top 29 US Stocks. In this piece, we will take ...

Merck's consistent dividend payments over 34 years, healthy balance sheet, and attractive valuation highlight its investment ...

Six projects involving eleven scientific institutions from six European countries are supported by Merck KGaA, Darmstadt, Germany and Intel The focus is on the application of Artificial Intelligence ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Jannie Oosthuizen, president, Human Health U.S., and Dr. Joerg Koglin, senior vice president and head of ...

Broadcom expanded its multi-year partnership with Telia Company to advance telecom and cloud infrastructure using VMware's ...

Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...

Merck KGaA is a healthcare/pharma company that I have been covering and investing in for about 2 years at this point. Q2 2024 ...